Innovation and technology transfer are fundamental at 4CB, where projects are driven to translate leading cancer research into real-world clinical solutions. A clear example of this commitment is the group of active cancer spin-offs, which translate the latest biomedical discoveries into real patient care, helping improve diagnosis, personalized treatment, and the development of new solutions to meet the challenges in this field.
Related News
Research
December 16 2025
2025-12-16
Institutional
December 1 2025
2025-12-01